Tania Acosta Vergara is physician at the free University of Barranquilla (Colombia 1992), diploma in upper management at the Industrial University of Santander (Colombia 1999), management in health services and quality management and medical auditing at the University of the North (Colombia 2004 and 2005, respectively), master's degree in international public health at the National School of Health ISCIII (Madrid, Spain 2006) and master's degree in epidemiology and public health from the University Rey Juan Carlos (Madrid, Spain 2008, currently PhD candidate). She has worked in the past 5 years with the Foundation of Biomedical Research of the University Hospital La Paz in Madrid, Spain, coordinating projects for the prevention of Type 2 diabetes and Latin America projects for the prevention of cardiovascular and metabolic risk factors. She has participated as an invited teacher in summer courses organized by the Complutense University (Madrid, Spain 2009), and in the publication of different guides for Type 2 diabetes prevention for at-risk people at a European level.
Rafael Gabriel MD, Salamanca University. Specialist in Internal Medicine, University of Madrid. PhD in Epidemiology, University of Texas School of Public Health (TX, USA). Fellowship in Genetic Epidemiology, Baylor College of Medicine (TX, USA). Chief, Clinical Epidemiology Unit; Co-Director of the Spanish Cochrane Network; Professorship iof Preventive Medicine and Public Health, Autonomous University (Madrid, Spain). Head, Clinical Epidemiology Division, University Hospital La Paz (Madrid, Spain). Executive member of RECAVA (the Cardiovascular Research Network of the Spanish Ministry of Health). Coordinator of the Iberamerican Network for the Prevention of Cardio-Metabolic diseases (IBERCARMEN).
Jaakko Tuomilehto is Professor Emeritus of Public Health of the University of Helsinki, Finland, and is currently working as the Professor of Vascular Prevention at the Danube-University Krems in Krems, Austria. He obtained his medical degree at the University of Turku, Finland. His research interests include the epidemiology and prevention of non-communicable diseases such as diabetes, cardiovascular disease and dementia. He has contributed to many landmark studies, including the Finnish Diabetes Prevention Study (DPS) that was the first (in 2001) to demonstrate a remarkable almost 60% reduction in the incidence of diabetes with lifestyle intervention. These findings have afterwards been replicated by several other trials, proving the concept. He also established large international collaborative studies of diabetes epidemiology, the Diabetes Epidemiology-Collaborative analysis of Diagnostic Criteria in Europe/Asia (DECODE/DECODA) studies that have formed the basis of the glucose criteria for the diagnosis of diabetes. He is actively involved in several committees, scientific organisations and advisory boards nationally and internationally. He has received many prestigious scientific awards, has contributed to over 1100 scientific publications, and is one of the most cited authors in the field of clinical medicine.